CVE-2026-105457
Received Received - Intake

Path Traversal in Liman MYS

Vulnerability report for CVE-2026-105457, including description, CVSS score, EPSS score, affected products, exploitability, helpful resources, and attack-flow context.

Publication date: 2026-10-28

Last updated on: 2026-10-28

Assigner: Computer Emergency Response Team of the Republic of Turkey

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: before 2.3.5-1132.

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published
2026-10-28
Last Modified
2026-10-28
Generated
2026-10-28
AI Q&A
2026-10-28
EPSS Evaluated
N/A
NVD
EUVD

Affected Vendors & Products

Showing 1 associated CPE
Vendor Product Version / Range
HAVELSAN Inc. Liman MYS 0

Helpful Resources

Exploitability

CWE
CWE Icon
KEV
KEV Icon
CWE ID Description
CWE-22 The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

Attack-Flow Graph

AI Quick Actions

Instant insights powered by AI
Executive Summary

This is a Path Traversal vulnerability in HAVELSAN Inc. Liman MYS versions before 2.3.5-1132. It allows attackers to access restricted directories outside the intended path by manipulating file paths in requests. This could lead to unauthorized file access or system compromise.

Impact Analysis

An attacker could exploit this to read sensitive files, access restricted directories, or perform unauthorized actions on the system. This may result in data breaches, system instability, or further network compromise depending on the exposed files.

Compliance Impact

This vulnerability could lead to unauthorized access to sensitive data, violating GDPR (data protection) and HIPAA (health information privacy) requirements. Non-compliance may result in legal penalties, fines, or reputational damage.

Mitigation Strategies

Update Liman MYS to version 2.3.5-1132 or later to address the path traversal vulnerability.

Chat Assistant

Ask questions about this CVE
Hi! I’m here to help you understand CVE-2026-105457. Ask me anything about the vulnerability, its impact, or mitigation strategies.
0/70

EPSS Chart